|
2010-12-20 |
EPANEM-III |
CIGB |
Registered |
|
2010-12-20 |
AntiCEA M3-I |
CIGB |
Registered |
|
2010-12-24 |
Toxicological evaluation of the humanized Anti-CD6 MAb T1h in Rheumatoid Arthritis Patients |
CIM |
Registered |
|
2010-12-24 |
Pharmacokinetics of intralesional EGF in patients with diabetic foot ulcers. |
CIGB |
Registered |
|
2010-12-24 |
Clinical trial, phase II, to evaluate rhEGF efficacy and safety at a dose of 25 or 75 micrograms intralesionally in patients with diabetic foot ulcer (Wagner grade 1 or 2). |
CIGB |
Registered |
|
2010-12-24 |
InCCNM -I |
CIGB |
Registered |
|
2010-12-24 |
Application of CIGB-128 in keloid patients undergoing surgical exeresis. |
CIGB |
Registered |
|
2010-12-24 |
CIGB-128 administration to patients with surgically-treated keloids. |
CIGB |
Registered |
|
2010-12-27 |
1E10 anti-idiotype vaccine, metastatic breast cancer, phase II |
CIM |
Registered |
|
2010-12-27 |
Evaluation of Safety and Efficacy of T1h (anti-CD6) as Monotherapy and in Combination with Methotrexate in Patientes with Rheumatoid Arthritis |
CIM |
Registered |
|
2010-12-27 |
188Re-marked Ior C5 MAb in persistent or relapsing ovary epithelial cancer, phase I. |
CIM |
Registered |
|
2010-12-27 |
Clinical trial, phase II: Evaluation of TheraCIM hR3 MaB combined with chemo- and radio-therapy to treat patients with epithelial tumors in neck of the uterus, stage III. |
CIM |
Registered |
|
2010-12-27 |
Hebervis administration in patients suffering from buccal mucositis caused by chemotherapy [unsealed |
CIGB |
Registered |
|
2010-12-28 |
Anti-idiotype 1E10 vaccine in advanced non- small cell lung (NSCLC) patients |
CIM |
Registered |
|
2010-12-28 |
Anti-idiotype 1E10 vaccine in the treatment of patients with small cell lung (SCLC) patients |
CIM |
Registered |
|
2010-12-28 |
h-R3 MaB and radiotherapy in pediatric patients with intrinsic diffuse astrocytomas of brain stem, phase II. |
CIM |
Registered |
|
2010-12-28 |
hR3 MaB and radiotherapy in highly malignant astrocytic tumors, phase III. |
CIM |
Registered |
|
2010-12-28 |
InCarbacel-II |
CIGB |
Registered |
|
2010-12-29 |
h-R3 MAb combined with radio chemotherapy to treat non-surgical esophagus tumors of epithelial origin. |
CIM |
Registered |
|
2010-12-29 |
NAcGM3/VSSP/Montanide ISA 51 formulation in HIV, phase II. |
CIM |
Registered |
